At iFyber, scientists are involved in every step of the project – from initial conversations and proposals to data analysis and reporting. We strive to build a culture of collaboration that fosters innovative and creative problem solving through the open exchange of information and ideas. The strong relationships we build with our clients and within the iFyber team are paramount to our success in delivering high-quality service and fast, reliable results.

Greg Mouchka


Greg joined iFyber as president in 2016 and is responsible for providing strategic leadership to the organization and creating and implementing processes supporting our core mission. He brings over 15 years of industry experience working with a range of companies, from medical device start-ups to mature established organizations. With a strong cross-functional background and understanding of the product development process, Greg has developed and executed the business and development plans of large multi-stakeholder projects for both medical device and applied market technologies. Over the last four years iFyber has increased in size by four-fold under Greg’s leadership, and he continues to successfully expand the business and our offerings through the development of successful corporate and government relationships and by building and maintaining a dynamic and innovative team.

Greg holds a B.S. and M.S. in mechanical engineering from Oregon State University.

Aaron Strickland, Ph.D.

Vice President of Research and Development

Aaron is the co-founder of iFyber and the technical lead for the organization. He brings over 20 years of research experience across a diverse array of fields, including synthetic chemistry, analytical chemistry, microbiology and molecular biology, and nanotechnology. Aaron leads multidisciplinary teams as the principle investigator and study director on both corporate-funded projects and federal grants and contracts for the National Science Foundation, the National Institutes of Health, US Navy, US Army, US Air Force, and DARPA. As technical lead, he plays a key business development role by facilitating exploratory and collaborative project conversations with potential and current clients. During method development efforts and study execution, Aaron is the primary resource for creative problem solving and experimental design when overcoming methodological or technical hurdles. In addition, he chairs the iFyber Scientific Advisory Board and SABs for corporate customers.

Aaron received his Ph.D. in chemistry from the University of Wyoming and performed postdoctoral work in microbiology and biotechnology at Cornell University.

Nina Bionda, Ph.D.

Director of Microbiological Services

Nina has been with iFyber since 2015 and leads the antimicrobial and anti-biofilm efforts. As principle investigator and study director Nina designs and manages corporate-funded projects and federal grants and contracts from the National Institutes of Health, Center for Disease Control, and Department of Defense. Nina has extensive experience with in vitro and ex vivo biofilm model method development and performing technology assessments for medical device and wound care technologies. She diligently works with clients to identify the appropriate testing strategy for their products based on intended use and, as subject matter expert, provides scientific support for clients during FDA meetings and resulting submissions. Within these roles, Nina excels at building and maintaining client, collaborator, and team relationships and efficiently organizing and executing project plans to deliver on time, quality results and analyses.

Nina received her Ph.D. in bioorganic and medicinal chemistry at Florida Atlantic University and completed postdoctoral work at the University of Rochester.

Devin Zysling Craven, Ph.D.

Director of Quality and Regulatory Services

Devin joined the iFyber team in 2019 and brings extensive product development and project management experience within regulated industry. Devin has spent 10 years in the medical device business directing cross-functional product development teams, designing regulatory strategies, and leading verification and clinical validation testing efforts for FDA submissions. Devin has a strong background in the identification, design, and execution of project testing plans for regulated and research use only technologies and applies these skills at iFyber to identify new models that address client testing and product development needs. In addition, she provides regulatory expertise and project management leadership in support of both corporate and grant-based projects.

Devin holds a Ph.D. in biology from Indiana University and completed her postdoctoral work at Cornell University in the Department of Population Medicine and Diagnostic Services.